Liver health may change how weight drug works
NCT ID NCT05564104
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This study looked at how the body handles cagrilintide, a drug being developed for weight management, in people with different levels of liver function. It also measured how well the drug is absorbed when injected under the skin versus into a vein. The study involved 32 adults and did not provide any treatment benefit—it was designed to gather important safety and dosing information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APEX Research
München, 81241, Germany
-
Pharmaceutical Research Associates CZ, s.r.o.
Prague, 17000, Czechia
-
Summit Clinical Research s.r.o.
Bratislava, 83101, Slovakia
-
Summit Clinical Research s.r.o.
Malacky, 901 22, Slovakia
Conditions
Explore the condition pages connected to this study.